KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023)

Ginkgo Bioworks Holdings' Change in Working Capital history spans 2 years, with the latest figure at $4.7 million for Q2 2023.

  • For Q2 2023, Change in Working Capital rose 76.52% year-over-year to $4.7 million; the TTM value through Jun 2023 reached $18.6 million, changed N/A, while the annual FY2022 figure was $10.8 million, N/A changed from the prior year.
  • Change in Working Capital reached $4.7 million in Q2 2023 per DNA's latest filing, down from $8.5 million in the prior quarter.
  • In the past five years, Change in Working Capital ranged from a high of $8.5 million in Q1 2023 to a low of $2.7 million in Q1 2022.